Contineum Therapeutics

San Diego, United States

Contineum Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.

Dec 2025

Post-IPO Equity

Biotechnology Health Care Pharmaceutical Therapeutics

Top Investors

Perceptive AdvisorsSamsara BioCapitalVersant VenturesCasdin CapitalHadean Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Contineum Therapeutics

Who are Contineum Therapeutics's investors?

Contineum Therapeutics's investors include Perceptive Advisors, Samsara BioCapital, Versant Ventures, Casdin Capital, Hadean Ventures.

Where is Contineum Therapeutics headquartered?

Contineum Therapeutics is headquartered in San Diego, United States.

What does Contineum Therapeutics do?

Contineum Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.

What stage is Contineum Therapeutics at?

Contineum Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 11, 2025.

MLA

"Contineum Therapeutics — Funding & Investors." VCBacked, December 11, 2025, https://www.vcbacked.co/company/contineum-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2025). Contineum Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/contineum-therapeutics

Wikipedia (cite web)

{{cite web |title=Contineum Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/contineum-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 11, 2025.